{"title":"Establishment of Reference Intervals for Serum Uric Acid Among Adults in China","authors":"Jiashu Yang, Junyi Wu, Qing Liu, Jingzhu Nan, Huai Zhao, Hui Yuan","doi":"10.1002/ila2.70018","DOIUrl":"https://doi.org/10.1002/ila2.70018","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The reference interval (RI) for serum uric acid (SUA) is a critical parameter for clinical diagnosis. However, systematic studies reflecting SUA levels across different regions in China are lacking. We aim to establish reference intervals for SUA using samples from multiple centers across China.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This cross-sectional study collected serum samples from 9314 healthy individuals across 6 regions in China (Shenyang, Yinchuan, Chengdu, Hangzhou, Changsha, and Nanning) between June and December 2020. The samples were analyzed using standardized methods, and non-parametric statistics were applied to assess differences in SUA levels.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The analysis revealed significant sex-based differences in SUA levels. The mean SUA level was 345.3 μmol/L in men and 276.9 μmol/L in women. The RI for men was 215.5–494.3 μmol/L, while that for women was 180.3–425.7 μmol/L. When stratified by sex and age, the RI for men aged 18–29 years was 226.4–508.9 μmol/L, and that for men aged 30–100 years was 213.4–485.1 μmol/L. For women, the RIs were 184.1–430.4 μmol/L (18–29 years), 176.5–414.1 μmol/L (30–49 years), 183.2–422.1 μmol/L (50–59 years), 185.8–429.2 μmol/L (60–79 years), and 194.5–478.6 μmol/L (80–100 years). Regional analysis also showed significant variation in SUA levels: the RI was 194.9–496.2 μmol/L in Shenyang, 192.5–447.8 μmol/L in Changsha, and 187.1–468.3 μmol/L for the combined regions of Nanning, Hangzhou, Chengdu, and Yinchuan.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>We successfully established RIs for SUA across different age groups, sexes, and geographic regions in China.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"3 2","pages":"209-220"},"PeriodicalIF":0.0,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.70018","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144519843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
iLABMEDPub Date : 2025-06-04DOI: 10.1002/ila2.70006
Jiuxin Qu, Hongzhou Lu
{"title":"iLABMED in the AI Era: Redefining Laboratory Medicine Through ChatGPT, DeepSeek and Beyond","authors":"Jiuxin Qu, Hongzhou Lu","doi":"10.1002/ila2.70006","DOIUrl":"https://doi.org/10.1002/ila2.70006","url":null,"abstract":"<p>Trends and future directions for laboratory medicine in the AI era.\u0000 <figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure></p>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"3 2","pages":"206-208"},"PeriodicalIF":0.0,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.70006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144519773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
iLABMEDPub Date : 2025-05-30DOI: 10.1002/ila2.70019
Xin Qian, Yuxin Zhang, Yilin Ye, Qiange Lin, Junyou Lin, Xinrong Lu, Li Chen, Guiqin Sun
{"title":"Rare Infectious Diseases: Detection and Clinical Implications","authors":"Xin Qian, Yuxin Zhang, Yilin Ye, Qiange Lin, Junyou Lin, Xinrong Lu, Li Chen, Guiqin Sun","doi":"10.1002/ila2.70019","DOIUrl":"https://doi.org/10.1002/ila2.70019","url":null,"abstract":"<p>Rare infectious diseases are infections that are uncommon, have a low incidence, and are caused by newly emerging pathogens, cross-species or ectopic infections, or host immunodeficiencies. The detection and diagnosis of rare infections is one of the main reasons for misdiagnosis and missed diagnosis. Traditional detection techniques such as microbial cultivation and isolation or polymerase chain reaction often fail to meet the clinical demands for timeliness, accuracy, and sensitivity. Metagenomic next-generation sequencing involves pan-nucleic acid testing conducted directly using specimens to facilitate rapid identification of rare or unidentified pathogens. Despite the availability of various techniques, advanced methods in clinical practice are necessary to achieve timely clinical diagnosis of rare infections. In this review, we summarize the definition and clinical significance of rare infectious diseases as well as the current detection methods, limitations, and future research areas for their detection.</p>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"3 2","pages":"148-157"},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.70019","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144520204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Development of an Enzymatic Recombinase Amplification Assay for the Rapid Detection of Plasmodium Nucleic Acids","authors":"Xinxin Yang, Xiaoxue Lu, Junlian Yang, Wen Xu, Qian Li, Weiwei Chen","doi":"10.1002/ila2.70014","DOIUrl":"https://doi.org/10.1002/ila2.70014","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Malaria remains a global health challenge, with 249 million cases and 608,000 deaths reported in 2022. While China achieved malaria elimination, imported cases surged by 194.4% in 2023, underscoring the need for rapid diagnostics. Traditional methods like microscopy and rapid diagnostic tests (RDTs) face limitations in sensitivity and infrastructure requirements. This study aimed to establish and optimize a “one-pot” enzymatic recombinase amplification (ERA) assay for the molecular detection of <i>Plasmodium falciparum</i> and <i>Plasmodium vivax</i>, and to evaluate the efficacy of this assay through methodological verification and clinical performance.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We designed a specific ERA assay targeting the conserved regions of <i>P. falciparum</i> and <i>P. vivax</i> genetic material. We evaluated the sensitivity and specificity of this assay using synthetic plasmids and genomic material. Additionally, we tested the stability of the reaction by incorporating potential interfering substances into the reaction system. Finally, we analyzed the detection performance of the ERA method against real-time fluorescent quantitative PCR and rapid diagnostic tests using clinical samples.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The detection process could be completed within 25 min at 35°C–40°C, and the results could be interpreted either under UV light or using a GeneScope instrument. The detection limit of the ERA assay was 250 copies/mL, which was 40 times more sensitive than fluorescent quantitative PCR. When evaluating the clinical performance using 75 clinical specimens, the detection rate of the ERA method was 94.54% compared with 89.09% for fluorescent quantitative PCR. The ERA assay and fluorescent quantitative PCR can achieve positive detection when blood samples were diluted 1024 times or even 4096 times. Comparatively, the detection capabilities of rapid diagnostic tests were significantly lower than that of the ERA assay.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The ERA method shows good performance in the detection of <i>P. falciparum</i> and <i>P. vivax</i>, and can be used as a complementary tool for malaria screening and clinical diagnosis.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"3 2","pages":"182-190"},"PeriodicalIF":0.0,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.70014","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144519821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
iLABMEDPub Date : 2025-05-12DOI: 10.1002/ila2.70017
Jiahao Wang, Guiqin Dai, Pengfei Zhao, Mingbin Zheng, Li Wei, Hongzhou Lu
{"title":"Single-Cell Metabolic Labeling Probe for Diagnosing Tuberculous Meningitis: A Case Report","authors":"Jiahao Wang, Guiqin Dai, Pengfei Zhao, Mingbin Zheng, Li Wei, Hongzhou Lu","doi":"10.1002/ila2.70017","DOIUrl":"https://doi.org/10.1002/ila2.70017","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <p>Tuberculous meningitis (TBM), an extrapulmonary form of tuberculosis (TB), is characterized by low bacterial load and lacks efficient diagnostic techniques, often leading to delayed diagnosis and high rates of mortality and disability. We present a case highlighting the superior performance of a single-cell metabolic labeling probe for tuberculosis (SCMLP-TB) in achieving rapid and accurate diagnosis of TBM. A 16-year-old girl had a 2-month history of refractory fever and worsening headache. Brain magnetic resonance imaging showed slightly abnormal signals in the right frontal lobe sulci. Standard diagnostic methods such as acid-fast staining, mycobacterial culture, and cerebrospinal fluid analysis all yielded negative results. SCMLP-TB successfully detected <i>Mycobacterium tuberculosis</i> in cerebrospinal fluid within 2 h in this case of clinically suspected TBM. Metagenomic next-generation sequencing later confirmed this finding. An anti-tuberculosis four-drug fixed-dose combination regimen was initiated on day 7 of hospitalization, resulting in gradual symptom and radiological improvement after 8-month follow-up. This first clinical application of the SCMLP-TB technology for diagnosing TBM underscores its value in point-of-care testing for paucibacillary TB infection.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"3 2","pages":"201-205"},"PeriodicalIF":0.0,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.70017","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144520124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Rapid Diagnostic Testing for Infective Endocarditis and Myocarditis Using Nanopore Targeted Sequencing","authors":"Aisi Fu, Xian Wang, Zhiyong Shen, Jiashuang Gu, Ting Zhang, Feiyan Wang, Shiyu Jia, Linmei Yang, Feng Li, Jie Geng, Jun Cheng","doi":"10.1002/ila2.70016","DOIUrl":"https://doi.org/10.1002/ila2.70016","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Infective endocarditis (IE) and myocarditis are serious heart diseases that can lead to life-threatening complications. These illnesses can have infectious origins, including viral, bacterial, or fungal pathogens. Traditional detection methods, such as culture-based methods, have limited ability to detect causative pathogens because of antibiotic use and the difficulty in cultivating intracellular and fastidious bacteria as well as viruses. In clinical settings, rapid diagnostics for pathogen identification are essential for timely treatment and appropriate antimicrobial therapy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We successfully developed a method based on nanopore targeted sequencing (NTS) with pathogen-specific panels for testing myocarditis and IE. As part of this pilot study, a sample-to-results protocol was developed with an optimized in-house pipeline and bioinformatics analysis solution.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The performance of NTS met our expectations for sensitivity, specificity, and turnaround time. The pathogen-specific panel testing was accomplished in a 10-h turnaround time, achieving a detection limit of 20 copies/test for the IE target panel and 10 copies/test for the myocarditis target panel. NTS achieved a clinical performance of 85.0% sensitivity and 96.3% specificity compared with culture testing methods, using 74 clinical specimens from patients (53 male, 21 female) associated with IE.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The rapid turnaround time of NTS is advantageous for managing acute infections, such as IE and myocarditis. NTS is a powerful tool for rapidly diagnosing infections in IE and myocarditis with significant potential for broader clinical applications.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"3 2","pages":"191-200"},"PeriodicalIF":0.0,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.70016","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144520001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Underlying Mechanism of Jiuwei Shengmai Powder in Improving Myocardial Hypoxia at High Altitude Based on Network Pharmacology and Molecular Docking","authors":"Cong Wu, Yanjuan Zhu, Changpeng Xie, Haobo Liu, Yuanming Pan, Chang'e Liu","doi":"10.1002/ila2.70011","DOIUrl":"https://doi.org/10.1002/ila2.70011","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>High altitude shock is attributed to myocardial ischemia and hypoxia. Jiuwei Shengmai powder has positive impacts on human physiology. However, it is unknown if it can mitigate myocardial ischemia and hypoxia. This study aimed to postulate the molecular mechanism that relieves myocardial hypoxia injury in officers and soldiers at high altitude after ingesting Jiuwei Shengmai powder by using network pharmacology and molecular docking.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The effective components and potential targets of Jiuwei Shengmai powder were detected by databases such as the traditional Chinese medicine systems pharmacology (TCMSP), PubChem, and UniProt. Target genes related to myocardial hypoxia injury were identified using Gene Cards, Online Mendelian Inheritance in Man, DrugBank, DisGeNET, the Comparative Toxicogenomics Database, and other databases. CytoScape was used to construct a “drug-active ingredient-target gene” network. Protein-protein interactions (PPIs) were predicted using the STRING database. Core gene target data were analyzed using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment utilizing R packages, while Autodock Vina was used to verify the molecular docking simulation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>One hundred and sixteen active ingredients were identified in Jiuwei Shengmai powder and were shown to target 197 genes. Of these, 3073 core target genes were related to myocardial hypoxia injury, and 130 core genes were obtained after Veen intersection. There were 129 PPI nodes and 1769 edges. The docking binding energy was ≤ −5.0 kcal·mol<sup>−1</sup>, indicating strong binding between the active compounds and targets. Quercetin and kaempferol are the main components in Jiuwei Shengmai powder that relieve myocardial hypoxia injury. Their core targets are interleukin-6 and activated cysteine proteinase-3 antibody, which are mainly related to PI3K-Akt-, mitogen-activated protein kinase (MAPK), tumor necrosis factor (TNF), and interleukin 17 (IL-17) signaling pathways.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This study provides a strong theoretical basis to understand the interaction of the components in Jiuwei Shengmai powder with human genes and proteins that should help to plan biochemical studies to better understand myocardial hypoxia injury mitigation.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"3 2","pages":"230-239"},"PeriodicalIF":0.0,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.70011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144520002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
iLABMEDPub Date : 2025-05-02DOI: 10.1002/ila2.70015
Xiaoyan Tan, Yongcong Li, Xufu Xiang, Wei Wu, Gang Wang, Sai Zhang
{"title":"Rapid and Visual Detection of Mycobacterium tuberculosis Complex Based on Multiplex Recombinase Polymerase Amplification","authors":"Xiaoyan Tan, Yongcong Li, Xufu Xiang, Wei Wu, Gang Wang, Sai Zhang","doi":"10.1002/ila2.70015","DOIUrl":"https://doi.org/10.1002/ila2.70015","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Tuberculosis (TB) remains a leading cause of mortality worldwide, particularly in developing nations. Currently, available diagnostic methods are often too costly or insufficiently sensitive for effective use in low- and middle-income countries. Developing a rapid, convenient, and accurate method for detecting the <i>Mycobacterium tuberculosis</i> complex (MTBC) is crucial to curtail the spread of TB.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Primers and probes targeting conserved regions of <i>IS1081</i> were designed, and the RNase P gene was introduced as an internal control to prevent false-negative results. <i>M. tuberculosis</i> control was used to optimize the reaction temperature. Additionally, we calculated and compared the limit of detection, specificity, and coincidence rate between this platform and the TaqMan real-time fluorescence quantification method (RT-qPCR) using two sets of national reference panels and 10 strains of MTBC.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>An on-site MTBC-multiplex recombinase polymerase amplification (MTBC-mRPA) platform was established, with detection within 30 min over a broad temperature range (25°C–45°C). Probit analysis estimated a 95% limit of detection of 557.16 (95% confidence interval: 406.76–1062.67) bacteria/mL (<i>p <</i> 0.0001), close to the limit of detection of 461.84 (95% confidence interval: 342.55–881.57) bacteria/mL (<i>p <</i> 0.0001) of qPCR. The platform differentiated between non-tuberculous mycobacteria and other common respiratory bacteria, showing 100% specificity. The coincidence rate between multiplex real-time recombinase polymerase amplification (RT-mRPA) and RT-qPCR was 100%, indicating substantial similarity.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>A simple, rapid, and visual MTBC-mRPA platform coupled with rapid DNA extraction was developed for sensitive and specific detection of MTBC, especially suitable for on-site screening of TB in low-resource settings.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"3 2","pages":"171-181"},"PeriodicalIF":0.0,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.70015","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144519877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
iLABMEDPub Date : 2025-04-12DOI: 10.1002/ila2.70008
Xuemei Wei, Xu Zhang, Jiaqi Zhang, Lin Zhu, Guanghong Guo
{"title":"Serological Indicators and Survival Analysis of Synaptophysin-Positive Gastric Cancer Patients: A Retrospective Study","authors":"Xuemei Wei, Xu Zhang, Jiaqi Zhang, Lin Zhu, Guanghong Guo","doi":"10.1002/ila2.70008","DOIUrl":"https://doi.org/10.1002/ila2.70008","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>This study aims to determine prognostic indicators of synaptophysin (SYN) positive gastric cancer with neuroendocrine type by analyzing differences in serological indicators and survival between SYN-positive and SYN-negative gastric cancer patients and to provide a theoretical basis for the prognosis of patients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The medical records of 1298 gastric cancer patients who had received surgical treatment between January 2019 and December 2021 at The First Medical Center of Chinese PLA General Hospital were assessed, and 59 patients were enrolled in this study, to analyze serological indices and survival differences between patients with SYN-positive and SYN-negative gastric cancer.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>There were statistically significant differences between the expression of SYN and genetic history, tumor differentiation degree, and Lauren's typing (<i>p</i> = 0.036, 0.040, and 0.017, respectively). The level of neuron-specific enolase in SYN-positive patients was higher than that in SYN-negative patients (<i>p</i> = 0.027). The level of hemoglobin (Hb) and mean corpuscular hemoglobin (MCH) was lower in SYN-positive patients when compared with SYN-negative patients (<i>p</i> = 0.023 and 0.019, respectively). The survival time of SYN-positive gastric cancer patients was statistically significantly different from that of SYN-negative gastric cancer patients (<i>p</i> = 0.0255).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>SYN expression in patients with gastric cancer is correlated with the degree of differentiation and Lauren's typing. The prognosis of SYN-positive gastric cancer patients is worse than that of SYN-negative patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"3 2","pages":"221-229"},"PeriodicalIF":0.0,"publicationDate":"2025-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.70008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144519774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
iLABMEDPub Date : 2025-04-10DOI: 10.1002/ila2.70007
Zhiyun Hao, Minwei Li, Qiang Zhao, Liye Wang, Ting Liu, Chi Wang, Chengbin Wang
{"title":"Construction of Reporter Phage T4::Nluc and Its Application in the Detection of Escherichia coli in Urinary Tract Infections","authors":"Zhiyun Hao, Minwei Li, Qiang Zhao, Liye Wang, Ting Liu, Chi Wang, Chengbin Wang","doi":"10.1002/ila2.70007","DOIUrl":"https://doi.org/10.1002/ila2.70007","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Urinary tract infections (UTIs) are one of the most common infectious diseases worldwide, predominantly caused by <i>Escherichia coli</i>. We constructed a reporter phage T4::<i>Nluc</i> to achieve rapid, sensitive, and specific detection of <i>Escherichia coli</i> in UTIs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>T4::<i>Nluc</i> was constructed using the CRISPR/Cas9 system combined with homologous recombination and was confirmed through Sanger sequencing. The biological properties of T4 and T4::<i>Nluc</i> were compared. Time-luminescence curves were detected to investigate the limit of detection (LOD) and the influence of urine. Additionally, the specificity of T4::<i>Nluc</i> was examined by co-culturing it with other pathogens. In total, 104 urinary <i>Escherichia coli</i> isolates were collected to assess detection coverage. Finally, 698 urine samples were collected for clinical validation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>T4::<i>Nluc</i> was confirmed to be correct. The one-step growth curves of T4 and T4::<i>Nluc</i> were similar, but the optimal multiplicity of infection for T4 was 1, and that for T4::<i>Nluc</i> was 0.1, indicating that genetic modification had some effect. The LOD was 10<sup>4</sup> colony-forming unit/mL detected at 220 min. Urine did not affect detection and T4::<i>Nluc</i> did not cross-react with other pathogens. T4::<i>Nluc</i> could detect 38.46% of clinical strains, demonstrating higher sensitivity than the double-layer overlay assay (25.96%). In clinical urine samples, its detection sensitivity was 36.59%, and the specificity was 100%.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>T4::<i>Nluc</i> was successfully constructed and could detect <i>Escherichia coli</i> with superior sensitivity and specificity compared with traditional diagnostics, fulfilling the diagnostic criteria for UTIs while significantly reducing the detection time. This presented a novel approach for rapid and accurate detection of <i>E</i>. <i>coli</i> in UTIs.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"3 2","pages":"158-170"},"PeriodicalIF":0.0,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.70007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144520005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}